SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Y. Maruyama, M. Taniguchi, J. J. Kazama, K. Yokoyama, T. Hosoya, T. Yokoo, T. Shigematsu, K. Iseki, Y. Tsubakihara, A higher serum alkaline phosphatase is associated with the incidence of hip fracture and mortality among patients receiving hemodialysis in Japan, Nephrology Dialysis Transplantation, 2014,

    CrossRef

  2. 2
    Noriaki Sakamoto, Eiichi Ishikawa, Kazuyasu Aoki, Yoji Uemae, Yoji Komatsu, Akira Matsumura, Clinical Outcomes of Intracerebral Hemorrhage in Hemodialysis Patients, World Neurosurgery, 2014, 81, 3-4, 538

    CrossRef

  3. 3
    Yusuke Sakaguchi, Naohiko Fujii, Tatsuya Shoji, Terumasa Hayashi, Hiromi Rakugi, Yoshitaka Isaka, Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis, Kidney International, 2014, 85, 1, 174

    CrossRef

  4. 4
    Tadao Akizawa, Akira Saito, Fumitake Gejyo, Masashi Suzuki, Yoshiki Nishizawa, Yasuhiko Tomino, Yoshiharu Tsubakihara, Takashi Akiba, Hideki Hirakata, Yuzo Watanabe, Hideki Kawanishi, Masami Bessho, Yukio Udagawa, Kotonari Aoki, Yukari Uemura, Yasuo Ohashi, Impacts of Recombinant Human Erythropoietin Treatment During Predialysis Periods on the Progression of Chronic Kidney Disease in a Large-Scale Cohort Study (Co-JET study), Therapeutic Apheresis and Dialysis, 2014, 18, 2
  5. 5
    Kunihiro Yamagata, Takashi Yagisawa, Shigeru Nakai, Masaaki Nakayama, Enyu Imai, Motoshi Hattori, Kunitoshi Iseki, Takashi Akiba, Prevalence and incidence of chronic kidney disease stage G5 in Japan, Clinical and Experimental Nephrology, 2014,

    CrossRef

  6. 6
    Hideki Terashima, Mikio Kato, Masayuki Ebisawa, Hideki Kobayashi, Kanae Suzuki, Yoshikazu Nezu, Toshio Sada, R-268712, an orally active transforming growth factor-β type I receptor inhibitor, prevents glomerular sclerosis in a Thy1 nephritis model, European Journal of Pharmacology, 2014, 734, 60

    CrossRef

  7. You have free access to this content7
    Tadao Akizawa, Hideki Origasa, Chisato Kameoka, Yuichiro Kaneko, Shigenori Kawasaki, Randomized Controlled Trial of Bixalomer Versus Sevelamer Hydrochloride in Hemodialysis Patients With Hyperphosphatemia, Therapeutic Apheresis and Dialysis, 2014, 18, 2
  8. 8
    Yoshinari Oka, Masashi Miyazaki, Hiroaki Matsuda, Shigeko Takatsu, Ryouichi Katsube, Toshiko Mori, Kiyoto Takehara, Yuzo Umeda, Futoshi Uno, Sevelamer Hydrochloride Dose-Dependent Increase in Prevalence of Severe Acidosis in Hemodialysis Patients: Analysis of Nationwide Statistical Survey in Japan, Therapeutic Apheresis and Dialysis, 2014, 18, 1
  9. 9
    Masayuki Tanemoto, Masato Higaki, Keiko Amano, Daigo Toyoki, Shigeyuki Arai, Satoru Tomioka, Shunya Uchida, Sonographic detection of a radiolucent object in dialysis vascular access, Journal of Clinical Ultrasound, 2014, 42, 6
  10. 10
    Bruce M Robinson, Jinyao Zhang, Hal Morgenstern, Brian D Bradbury, Leslie J Ng, Keith P McCullough, Brenda W Gillespie, Raymond Hakim, Hugh Rayner, Joan Fort, Tadao Akizawa, Francesca Tentori, Ronald L Pisoni, Worldwide, mortality risk is high soon after initiation of hemodialysis, Kidney International, 2014, 85, 1, 158

    CrossRef

  11. 11
    Jumpei Hasegawa, Sachiko Wakai, A case of disseminated tuberculosis after the initiation of hemodialysis, CEN Case Reports, 2013, 2, 2, 252

    CrossRef

  12. 12
    Kenji Tsuchida, Jun Minakuchi, Clinical Benefits of Predilution On-Line Hemodiafiltration, Blood Purification, 2013, 35, s1, 18

    CrossRef

  13. 13
    Ryota Ikee, Masataka Tsunoda, Naomi Sasaki, Naritsugu Sato, Nobuo Hashimoto, Clinical factors associated with serum copper levels and potential effect of sevelamer in hemodialysis patients, International Urology and Nephrology, 2013, 45, 3, 839

    CrossRef

  14. 14
    EMANUELE MELIGA, MAURO DE BENEDICTIS, ANDREA GAGNOR, FEDERICO CONROTTO, MARCO NOVARA, INNOCENZO SCROCCA, FERDINANDO VARBELLA, SEBASTIANO MARRA, MARIA ROSA CONTE, Clinical Outcomes Following Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Bare Metal Stents in Patients on Chronic Hemodialysis, Journal of Interventional Cardiology, 2013, 26, 4
  15. 15
    Koji Nishida, Takeshi Kimura, Kazuya Kawai, Ichiro Miyano, Yoko Nakaoka, Satoshi Yamamoto, Noriyoshi Kaname, Shuichi Seki, Shoichi Kubokawa, Masahiko Fukatani, Naohisa Hamashige, Takeshi Morimoto, Kazuaki Mitsudo, Comparison of Outcomes Using the Sirolimus-Eluting Stent in Calcified Versus Non-Calcified Native Coronary Lesions in Patients On- Versus Not On-Chronic Hemodialysis (from the j-Cypher Registry), The American Journal of Cardiology, 2013, 112, 5, 647

    CrossRef

  16. 16
    Takashi Yasuda, Masayuki Endoh, Daisuke Suzuki, Asio Yoshimura, Terukuni Ideura, Kozo Tamura, Kouju Kamata, Yoshiyuki Toya, Satoshi Umemura, Kenjiro Kimura, Effects of valsartan on progression of kidney disease in Japanese hypertensive patients with advanced, predialysis, chronic kidney disease: Kanagawa Valsartan Trial (KVT), Hypertension Research, 2013, 36, 3, 240

    CrossRef

  17. 17
    Masaki Iwasaki, Nobuhiko Joki, Yuri Tanaka, Nobutaka Ikeda, Toshihide Hayashi, Shun Kubo, Takasuke Asakawa, Yasunori Takahashi, Koichi Hirahata, Yoshihiko Imamura, Hiroki Hase, Efficacy of N-terminal pro-brain natriuretic peptide digit number for screening of cardiac disease in new haemodialysis patients, Nephrology, 2013, 18, 7
  18. 18
    Kunitoshi Iseki, Nephrology for the people: Presidential Address at the 42nd Regional Meeting of the Japanese Society of Nephrology in Okinawa 2012, Clinical and Experimental Nephrology, 2013, 17, 4, 480

    CrossRef

  19. You have free access to this content19
    Shigeru Nakai, Yuzo Watanabe, Ikuto Masakane, Atsushi Wada, Tetsuo Shoji, Takeshi Hasegawa, Hidetomo Nakamoto, Kunihiro Yamagata, Junichiro James Kazama, Naohiko Fujii, Noritomo Itami, Toshio Shinoda, Takashi Shigematsu, Seiji Marubayashi, Osamu Morita, Seiji Hashimoto, Kazuyuki Suzuki, Naoki Kimata, Norio Hanafusa, Kenji Wakai, Takayuki Hamano, Satoshi Ogata, Kenji Tsuchida, Masatomo Taniguchi, Hiroshi Nishi, Kunitoshi Iseki, Yoshiharu Tsubakihara, Overview of Regular Dialysis Treatment in Japan (as of 31 December 2011), Therapeutic Apheresis and Dialysis, 2013, 17, 6
  20. 20
    Fumihiko Koiwa, Preface, Therapeutic Apheresis and Dialysis, 2013, 17,
  21. 21
    Yayoi Shiotsu, Yasukiyo Mori, Masato Nishimura, Tsuguru Hatta, Naoki Imada, Noboru Maki, Kumiko Iida, Noriyuki Iwamoto, Eiko Matsuoka, Keiichi Tamagaki, Atsushi Kosaki, Prognostic utility of plasma S100A12 levels to establish a novel scoring system for predicting mortality in maintenance hemodialysis patients: a two-year prospective observational study in Japan, BMC Nephrology, 2013, 14, 1, 16

    CrossRef

  22. 22
    Masayo Sato, Tetsuya Ogawa, Kuniaki Otsuka, Yoshitaka Ando, Kosaku Nitta, Stiffness parameter β as a predictor of the 4-year all-cause mortality of chronic hemodialysis patients, Clinical and Experimental Nephrology, 2013, 17, 2, 268

    CrossRef

  23. 23
    Kai Ishida, Manami Sawa, Kousaku Fujiwara, Minoru Hirose, Harukazu Tsuruta, Akihiro Takeuchi, Noriaki Ikeda, Study of Electrical Power Facilities and Measures for Planned Outages in Japanese Hemodialysis Clinics After the Great East Japan Earthquake, Therapeutic Apheresis and Dialysis, 2013, 17, 1
  24. 24
    Nanako Nakamura-Taira, Yoshimi Muranaka, Masako Miwa, Seikon Kin, Kei Hirai, Views of Japanese patients on the advantages and disadvantages of hemodialysis and peritoneal dialysis, International Urology and Nephrology, 2013, 45, 4, 1145

    CrossRef

  25. You have free access to this content25
    Shigeru Nakai, Kunitoshi Iseki, Noritomo Itami, Satoshi Ogata, Junichiro James Kazama, Naoki Kimata, Takashi Shigematsu, Toshio Shinoda, Tetsuo Shoji, Kazuyuki Suzuki, Masatomo Taniguchi, Kenji Tsuchida, Hidetomo Nakamoto, Hiroshi Nishi, Seiji Hashimoto, Takeshi Hasegawa, Norio Hanafusa, Takayuki Hamano, Naohiko Fujii, Ikuto Masakane, Seiji Marubayashi, Osamu Morita, Kunihiro Yamagata, Kenji Wakai, Atsushi Wada, Yuzo Watanabe, Yoshiharu Tsubakihara, An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2010), Therapeutic Apheresis and Dialysis, 2012, 16, 6